These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. FDA exploring safety aspects of cloned animals. Am J Vet Res; 2001 Oct; 62(10):1517. PubMed ID: 11592311 [No Abstract] [Full Text] [Related]
11. Communicating with the FDA: the "third rail" of a new model for drug development. Stanski DR; Orloff JJ J Clin Pharmacol; 2008 Feb; 48(2):144-5. PubMed ID: 18199890 [No Abstract] [Full Text] [Related]
12. The Vioxx debacle revisited. Good CB; Kelley CL Am J Med; 2005 Sep; 118(9):1055-6; author reply 1056-7. PubMed ID: 16164902 [No Abstract] [Full Text] [Related]
13. FDA pharmacogenomics guidance sends clear message to industry. Ratner M Nat Rev Drug Discov; 2005 May; 4(5):359. PubMed ID: 15902767 [No Abstract] [Full Text] [Related]
14. FDA regulations. FDA shuts down sale of unregulated HIV drug. AIDS Policy Law; 2004 Sep; 19(18):8. PubMed ID: 18680858 [No Abstract] [Full Text] [Related]
15. A baseline assessment of U.S. Naval food facilities using the Food Code's new risk-based inspection program. Boyd D J Environ Health; 2007 Nov; 70(4):27-30. PubMed ID: 18044250 [TBL] [Abstract][Full Text] [Related]
16. How celecoxib could be safer, how valdecoxib might have been. Cohen JS Ann Pharmacother; 2005 Sep; 39(9):1542-5. PubMed ID: 16076909 [TBL] [Abstract][Full Text] [Related]
17. FDA notifications. FDA approves raltegravir for HIV-1 treatment-naive patients. AIDS Alert; 2009 Sep; 24(9):106-7. PubMed ID: 19938313 [No Abstract] [Full Text] [Related]
18. Analysis and recommendations for agency action regarding nonsteroidal antiinflammatory drugs and cardiovascular risk. U.S. Food and Drug Administration J Pain Palliat Care Pharmacother; 2005; 19(4):83-97. PubMed ID: 16431839 [TBL] [Abstract][Full Text] [Related]
19. FDA notifications. FDA published 2 new rules regarding INDs. AIDS Alert; 2009 Nov; 24(11):130-1. PubMed ID: 19967790 [No Abstract] [Full Text] [Related]
20. FDA issues public health advisory recommending limited use of COX-2 inhibitors. S Afr Med J; 2005 Feb; 95(2):92. PubMed ID: 15751199 [No Abstract] [Full Text] [Related] [Next] [New Search]